Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others) and Application (Orthopedic Devices, Drug Delivery, and Others

Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others) and Application (Orthopedic Devices, Drug Delivery, and Others)

The bioresorbable polymers market was valued at US$ 3,260.07 million in 2021 and is projected to reach US$ 6,463.07 million by 2028. It is expected to grow at a CAGR of 10.3% from 2021 to 2028.

The rising demand for bioresorbable polymers for manufacturing medical implants is boosting the bioresorbable polymers market. Polymer materials, such as polylactic acid, polycaprolactone, Polydioxanone, and others, are widely used to manufacture screws, pins, rods, plates scaffolds, sutures, stents, and other bioabsorbable medical implant devices. During the recovery phase, the temporary implants gradually start dissolving and are entirely absorbed in the body after its function is performed. As the body itself absorbs these bioresorbable implants, the patient does not require a second surgical intervention to remove them. Hence, the demand for bioresorbable polymer implants is increasing and, subsequently, driving the bioresorbable polymer market.

The COVID-19 limited the chemicals and materials industry's operations, hampering many businesses globally. Supply chain disruptions and difficulty in procuring raw materials have restrained the bioresorbable polymers market to some extent. Delays in medical surgeries have been observed during this pandemic over the world. Although elective surgeries resumed in the UK (and many other countries as well) in mid-2020, most hospitals are functioning at a substantially reduced capacity, resulting in an ever-lengthening waitlist. The delay in medical surgeries has decreased the demand for medical and orthopedic devices, affecting the bioresorbable polymers market.

Bezwada Biomedical, LLC; Evonik Industries AG; Foster Corporation; Ashland; Musashino Chemical Laboratory, Ltd.; Huizhou Foryou Medical Devices Co., Ltd.; Polysciences, Inc.; BMG; Poly-Med Incorporated; And Reva Medical, LLC., are the key players in the bioresorbable polymers market.



The size of the global bioresorbable polymers market has been derived using primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights into the topic. Participants of this process include industry experts, such as VPs, business development managers, market intelligence managers, national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders, specializing in this market.

Reason to buy

Highlights key business priorities to assist companies realign their business strategies.
Features key findings and crucial progressive industry trends in the global bioresorbable polymers market, thereby allowing players to develop effective long-term strategies.
Develops/modifies business expansion plans by using substantial growth offering from developed and emerging markets.
Scrutinizes in-depth market trends as well as key market drivers and restraints.
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

The List of Companies - Bioresorbable Polymers Market

1. BMG Incorporated
2. Evonik Industries AG
3. Foster Corporation
4. Ashland Global Holdings Inc.
5. Poly-Med Incorporated
6. REVA Medical, LLC
7. Musashino Chemical Laboratory, Ltd
8. Huizhou Foryou Medical Devices Co., Ltd.
9. Polysciences Inc
10. Bezwada Biomedical LLC